Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 303

    1.

    Coagulation in sepsis: all bugs bite equally.

    Levi M, van der Poll T.

    Crit Care. 2004 Apr;8(2):99-100. Epub 2004 Feb 10.PMID: 15025767 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].

    Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF; PROWESS Sepsis Study Group.

    Crit Care. 2004 Apr;8(2):R82-90. Epub 2004 Feb 10.PMID: 15025782 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sepsis and disseminated intravascular coagulation.

    Levi M, de Jonge E, van der Poll T.

    J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):43-7. Review.PMID: 14760211 [PubMed - indexed for MEDLINE]Related articles

    4.

    Static and dynamic assessment of biomarkers in surgical patients with severe sepsis.

    Lowry SF, Awad S, Ford H, Cheadle W, Williams MD, Qualy RL, McCollam JS, Bates BM, Fry DE; PROWESS Surgical Evaluation Committee.

    Surg Infect (Larchmt). 2004 Fall;5(3):261-8.PMID: 15684797 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Investigation of hemostatic changes in patients with sepsis]

    Kim GY, Park SY, Yoon HJ, Suh JT, Kang SY, Lee WI.

    Korean J Lab Med. 2007 Jun;27(3):157-61. Korean. PMID: 18094569 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

    Dhainaut JF, Yan SB, Joyce DE, Pettilä V, Basson B, Brandt JT, Sundin DP, Levi M.

    J Thromb Haemost. 2004 Nov;2(11):1924-33.PMID: 15550023 [PubMed - indexed for MEDLINE]Related articles

    7.

    Infection and inflammation and the coagulation system.

    Levi M, Keller TT, van Gorp E, ten Cate H.

    Cardiovasc Res. 2003 Oct 15;60(1):26-39. Review.PMID: 14522404 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Clinical impact of novel anticoagulation strategies in sepsis.

    Opal SM.

    Curr Opin Crit Care. 2001 Oct;7(5):347-53. Review.PMID: 11805532 [PubMed - indexed for MEDLINE]Related articles

    9.

    New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology.

    Levi M, de Jonge E, van der Poll T.

    Ann Med. 2004;36(1):41-9. Review.PMID: 15000346 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C.

    Yan SB, Nelson DR.

    Crit Care Med. 2004 May;32(5 Suppl):S239-46.PMID: 15118525 [PubMed - indexed for MEDLINE]Related articles

    11.

    Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.

    de Jonge E, van der Poll T, Kesecioglu J, Levi M.

    Semin Thromb Hemost. 2001 Dec;27(6):667-74. Review.PMID: 11740690 [PubMed - indexed for MEDLINE]Related articles

    12.

    Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.

    Esmon CT.

    Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2. Review.PMID: 11445734 [PubMed - indexed for MEDLINE]Related articles

    13.

    Current clinical practice. DIC 2002: a review of disseminated intravascular coagulation.

    Toh CH, Dennis M.

    Hematology. 2003 Apr;8(2):65-71. Review.PMID: 12745654 [PubMed - indexed for MEDLINE]Related articles

    14.

    A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial.

    Wheeler A, Steingrub J, Schmidt GA, Sanchez P, Jacobi J, Linde-Zwirble W, Bates B, Qualy RL, Woodward B, Zeckel M.

    Crit Care Med. 2008 Jan;36(1):14-23.PMID: 18158435 [PubMed - indexed for MEDLINE]Related articles

    15.

    Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.

    Faust SN, Heyderman RS, Levin M.

    Crit Care Med. 2001 Jul;29(7 Suppl):S62-7; discussion S67-8. Review.PMID: 11445736 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.

    Levi M, de Jonge E, van der Poll T.

    Crit Care Med. 2001 Jul;29(7 Suppl):S90-4. Review.PMID: 11445740 [PubMed - indexed for MEDLINE]Related articles

    17.

    Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.

    De Backer D.

    Drug Saf. 2007;30(11):995-1010. Review.PMID: 17973539 [PubMed - indexed for MEDLINE]Related articles

    18.

    Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae.

    Vail GM, Xie YJ, Haney DJ, Barnes CJ.

    Infection. 2009 Aug;37(4):358-64. Epub 2009 Jan 23.PMID: 19169631 [PubMed - indexed for MEDLINE]Related articles

    19.

    Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness.

    Haley M, Cui X, Minneci PC, Deans KJ, Natanson C, Eichacker PQ.

    Curr Opin Infect Dis. 2004 Jun;17(3):205-11. Review.PMID: 15166822 [PubMed - indexed for MEDLINE]Related articles

    20.

    Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.

    Dhainaut JF, Yan SB, Cariou A, Mira JP.

    Crit Care Med. 2002 May;30(5 Suppl):S318-24. Review.PMID: 12004254 [PubMed - indexed for MEDLINE]Related articles